Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

P18.24.A GLIOBLASTOMA INVASION OF NEURAL STEM CELL REGIONS; MOLECULAR PATTERNS AND SURVIVAL RATES

View through CrossRef
Abstract BACKGROUND Glioblastoma is a very aggressive form of brain cancer and poses a challenge in treatment due to its profound heterogeneity and capacity for extensive infiltration into the brain parenchyma. Research has shown glioblastomas in close proximity to the ependyma have poorer survival rates. Therefore, our aim was to identify distinct molecular features of grade 4 glioma invading ependyma of lateral ventricles and neural stem cell region and the survival prognosis of these patients. MATERIAL AND METHODS Retrospective review of 180 patients with a new histologically confirmed diagnosis of grade 4 glioma between 2018 and 2019. Patients excluded if less than 18-years-old, did not have a histological diagnosis, or had missing data. Analysis of anonymised patient data were conducted with ethical consent from NHS GGC Caldicott Guardian. SPSS version-28 used for statistical analysis. RESULTS Average age of all patients was 59 +/-12.3 years with 54% male and 46% female. 170 tumours were identified as IDH-wildtype (IDHw), while 10 were IDH-mutant (IDHm). Of the total 180 patients, 77 tumours contacted the ependyma, with 10.4% being IDHm and 89.6% IDHw. 103 tumours were identified as ependymal non-contacting with 2% being IDHm and 98% IDHw. Statistically significance association found between IDH mutations and ependymal contact (p-value 0.02). For both groups, majority of the tumours were unmethylated, with 57% for contacting and 65% for non-contacting tumours. However, no statistically significant associations were observed between MGMT methylation status and ependymal-contact (p-value 0.35). For IDHw glioblastomas, over half of the tumours for ependymal contact and ependymal non-contact were unmethylated (61% and 65% respectively). Mean overall survival (OS) for all patients was 16.6 (CI 19.0, 14.1) months. OS was lower in ependymal-contact tumours compared to non-ependymal contacting tumours (14.9 months compared to 17.5 months respectively, however this was not significant (p-value 0.11). Sub-analysis of IDHw glioblastomas showed reduced survival by ependymal contact with mean OS of 11.9 months compared to 17.4 months for non-contacting IDHw tumours (p-value 0.004). Mean epicentre distance for ependymal contacting MGMT methylated tumours was 17.7mm compared to 15.6mm for MGMT unmethylated contacting tumours. Statistically significant association found between epicentre distance and methylation status of ependymal-contacting tumours (p-value 0.008). No statistically significant associations found between epicentre distance and IDH status of ependymal-contacting tumours (p-value 0.23). CONCLUSION We have found that ependymal contacting tumours are more likely to be IDHw and MGMT unmethylated. Adjusted analysis showed ependymal-contact to lower survival rates and IDHw contacting tumours to also have poorer survival outcomes.
Title: P18.24.A GLIOBLASTOMA INVASION OF NEURAL STEM CELL REGIONS; MOLECULAR PATTERNS AND SURVIVAL RATES
Description:
Abstract BACKGROUND Glioblastoma is a very aggressive form of brain cancer and poses a challenge in treatment due to its profound heterogeneity and capacity for extensive infiltration into the brain parenchyma.
Research has shown glioblastomas in close proximity to the ependyma have poorer survival rates.
Therefore, our aim was to identify distinct molecular features of grade 4 glioma invading ependyma of lateral ventricles and neural stem cell region and the survival prognosis of these patients.
MATERIAL AND METHODS Retrospective review of 180 patients with a new histologically confirmed diagnosis of grade 4 glioma between 2018 and 2019.
Patients excluded if less than 18-years-old, did not have a histological diagnosis, or had missing data.
Analysis of anonymised patient data were conducted with ethical consent from NHS GGC Caldicott Guardian.
SPSS version-28 used for statistical analysis.
RESULTS Average age of all patients was 59 +/-12.
3 years with 54% male and 46% female.
170 tumours were identified as IDH-wildtype (IDHw), while 10 were IDH-mutant (IDHm).
Of the total 180 patients, 77 tumours contacted the ependyma, with 10.
4% being IDHm and 89.
6% IDHw.
103 tumours were identified as ependymal non-contacting with 2% being IDHm and 98% IDHw.
Statistically significance association found between IDH mutations and ependymal contact (p-value 0.
02).
For both groups, majority of the tumours were unmethylated, with 57% for contacting and 65% for non-contacting tumours.
However, no statistically significant associations were observed between MGMT methylation status and ependymal-contact (p-value 0.
35).
For IDHw glioblastomas, over half of the tumours for ependymal contact and ependymal non-contact were unmethylated (61% and 65% respectively).
Mean overall survival (OS) for all patients was 16.
6 (CI 19.
0, 14.
1) months.
OS was lower in ependymal-contact tumours compared to non-ependymal contacting tumours (14.
9 months compared to 17.
5 months respectively, however this was not significant (p-value 0.
11).
Sub-analysis of IDHw glioblastomas showed reduced survival by ependymal contact with mean OS of 11.
9 months compared to 17.
4 months for non-contacting IDHw tumours (p-value 0.
004).
Mean epicentre distance for ependymal contacting MGMT methylated tumours was 17.
7mm compared to 15.
6mm for MGMT unmethylated contacting tumours.
Statistically significant association found between epicentre distance and methylation status of ependymal-contacting tumours (p-value 0.
008).
No statistically significant associations found between epicentre distance and IDH status of ependymal-contacting tumours (p-value 0.
23).
CONCLUSION We have found that ependymal contacting tumours are more likely to be IDHw and MGMT unmethylated.
Adjusted analysis showed ependymal-contact to lower survival rates and IDHw contacting tumours to also have poorer survival outcomes.

Related Results

Stem cells
Stem cells
What is a stem cell? The term is a combination of ‘cell’ and ‘stem’. A cell is a major category of living thing, while a stem is a site of growth and support for something else. In...
Investigating the role of the apelinergic system in glioblastoma
Investigating the role of the apelinergic system in glioblastoma
<p>Elucidating the molecular signalling circuitry that underpins the pathogenesis of cancers is critical to understanding and developing effective treatment paradigms for can...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Glioblastoma: Características Histopatológicas e Marcadores Diagnósticos
Glioblastoma: Características Histopatológicas e Marcadores Diagnósticos
O glioblastoma representa a neoplasia maligna primária mais comum e agressiva do sistema nervoso central em adultos, caracterizando-se por um comportamento biológico altamente infi...
Complexity of the erythroid transcription factor NF-E2 as revealed by gene targeting of the mouse p18 NF-E2 locus.
Complexity of the erythroid transcription factor NF-E2 as revealed by gene targeting of the mouse p18 NF-E2 locus.
High-level globin expression in erythroid precursor cells depends on the integrity of NF-E2 recognition sites, transcription factor AP-1-like protein-binding motifs, located in the...
Understanding glioblastoma : cell identity in tissue space
Understanding glioblastoma : cell identity in tissue space
<p dir="ltr"><b>Abstract</b></p><p dir="ltr">Glioblastoma is the most prevalent form of brain cancer among adults. Inherently malignant and aggressive...
Understanding glioblastoma : cell identity in tissue space
Understanding glioblastoma : cell identity in tissue space
<p dir="ltr"><b>Abstract</b></p><p dir="ltr">Glioblastoma is the most prevalent form of brain cancer among adults. Inherently malignant and aggressive...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

Back to Top